COCM
FLGT icon

Charter Oak Capital Management’s Fulgent Genetics FLGT Stock Holding History

Charter Oak Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7
Closed – – 410
2022
Q2 		$0 Sell
7
-49
-88% -$2.69K ﹤0.01% 945
2022
Q1 		$3K Buy
56
+49
+700% +$3.23K ﹤0.01% 832
2021
Q4 		$1K Hold
7
– – ﹤0.01% 810
2021
Q3 		$1K Hold
7
– – ﹤0.01% 784
2021
Q2 		$1K Hold
7
– – ﹤0.01% 770
2021
Q1 		$1K Buy
+7
New +$723 ﹤0.01% 743

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charter Oak Capital Management's FLGT Position: Q3 2022 in Review

Charter Oak Capital Management sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 7 shares.

Charter Oak Capital Management first reported a position in FLGT in Q1 2021 and held it in 6 quarters. The position peaked at $3K in Q1 2022. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • Charter Oak Capital Management reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • Charter Oak Capital Management sold 7 Fulgent Genetics shares in Q3 2022.
  • Charter Oak Capital Management first reported a position in Fulgent Genetics in Q1 2021 and held it in 6 quarters.
  • Charter Oak Capital Management's Fulgent Genetics position peaked at $3K in Q1 2022.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.